Biomarin Pharmaceutical Inc
2017 Q1 - 2025 Q4 (35 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 900 | 0.0% | 15,137 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 830 | 0.0% | 15,320 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 465 | 0.0% | 8,460 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,515 | 0.0% | 21,433 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 951 | 0.0% | 14,473 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 604 | 0.0% | 8,589 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 626 | 0.0% | 7,598 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 458 | 0.0% | 5,200 | 3/31/2024 |
| 2023 Q4 | 8/15/2024 | 400 | 0.0% | 4,150 | 12/31/2023 |
| 2023 Q3 | 8/15/2024 | 526 | 0.0% | 5,941 | 9/30/2023 |
| 2023 Q2 | 8/15/2024 | 570 | 0.0% | 6,580 | 6/30/2023 |
| 2023 Q1 | 8/15/2024 | 705 | 0.0% | 7,249 | 3/31/2023 |
| 2022 Q4 | 8/15/2024 | 250 | 0.0% | 2,419 | 12/31/2022 |
| 2022 Q3 | 8/15/2024 | 180 | 0.0% | 2,119 | 9/30/2022 |
| 2022 Q2 | 8/15/2024 | 191 | 0.0% | 2,307 | 6/30/2022 |
| 2022 Q1 | 8/15/2024 | 184 | 0.0% | 2,387 | 3/31/2022 |
| 2021 Q4 | 8/30/2024 | 193 | 0.0% | 2,187 | 12/31/2021 |
| 2021 Q3 | 8/30/2024 | 169 | 0.0% | 2,187 | 9/30/2021 |
| 2021 Q2 | 8/30/2024 | 54 | 0.0% | 650 | 6/30/2021 |
| 2021 Q1 | 8/30/2024 | 127 | 0.0% | 1,687 | 3/31/2021 |
| 2020 Q4 | 8/30/2024 | 152 | 0.0% | 1,737 | 12/31/2020 |
| 2020 Q3 | 8/30/2024 | 57 | 0.0% | 750 | 9/30/2020 |
| 2020 Q2 | 8/30/2024 | 43 | 0.0% | 350 | 6/30/2020 |
| 2020 Q1 | 8/30/2024 | 30 | 0.0% | 350 | 3/31/2020 |
| 2019 Q4 | 8/30/2024 | 30 | 0.0% | 350 | 12/31/2019 |
| 2019 Q3 | 8/30/2024 | 24 | 0.0% | 350 | 9/30/2019 |
| 2019 Q2 | 8/30/2024 | 30 | 0.0% | 350 | 6/30/2019 |
| 2019 Q1 | 8/30/2024 | 31 | 0.0% | 350 | 3/31/2019 |
| 2018 Q4 | 8/30/2024 | 30 | 0.0% | 350 | 12/31/2018 |
| 2018 Q3 | 8/30/2024 | 34 | 0.0% | 350 | 9/30/2018 |
| 2018 Q2 | 8/30/2024 | 33 | 0.0% | 350 | 6/30/2018 |
| 2018 Q1 | 8/30/2024 | 28 | 0.0% | 350 | 3/31/2018 |
| 2017 Q3 | 8/30/2024 | 9 | 0.0% | 100 | 9/30/2017 |
| 2017 Q2 | 8/30/2024 | 9 | 0.0% | 100 | 6/30/2017 |
| 2017 Q1 | 8/30/2024 | 9 | 0.0% | 100 | 3/31/2017 |